1
Views
0
CrossRef citations to date
0
Altmetric
Review

Lymph node imaging techniques in gynecologic malignancies: a systematic review of the literature

, &
Pages 163-178 | Published online: 10 Jan 2014

References

  • Horowitz NS, Dehdashti F, Herzog TJ et al. Prospective evaluation of FDG-PET for detecting pelvic and para-aortic lymph node metastasis in uterine corpus cancer. Gynecol. Oncol.95(3), 546–551 (2004).
  • Hardesty LA, Sumkin JH, Hakim C, Johns C, Nath M. The ability of helical CT to preoperatively stage endometrial carcinoma. Am. J. Roentgenol.176, 603–606 (2001).
  • Kinkel K, Kaji Y, Yu KK et al. Radiologic staging in patients with endometrial cancer: a meta-analysis. Radiology212(3), 711–718 (1999).
  • Todo Y, Sakuragi N, Nishida R et al. Combined use of magnetic resonance imaging, CA 125 assay, histologic type, and histologic grade in the predicition of lymph node metastasis in endometrial carcinoma. Am. J. Obstet. Gynecol.188, 1265–1272 (2003).
  • Arduino S, Leo L, Febo G, Tessarolo M, Wierdis T, Lanza A. Complications of pelvic and para-aortic lymphadenectomy in patients with endometrial cancer. Eur. J. Gynaecol. Oncol.18(3), 208–210 (1997).
  • Franchi M, Ghezzi F, Riva C, Miglierina M, Buttarelli M, Bolis P. Postoperative complications after pelvic lymphadenectomy for the surgical staging of endometrial cancer. J. Surg. Oncol.78(4), 232–237 (2001).
  • Kuoppala T, Tomas E, Heinonen PK. Clinical outcome and complications of laparoscopic surgery compared with traditional surgery in women with endometrial cancer. Arch. Gynecol. Obstet.270(1), 25–30 (2004).
  • Pilka R, Kudela M, Dzvincuk P, Lubusky D. Preoperative detection of lymph nodes by means of computer tomography in patients with endometrial carcinoma. Ceska Gynekol.69, 237–239 (2004).
  • Connor JP, Andrews JI, Anderson B, Buller RE. Computed tomography in endometrial carcinoma. Obstet. Gynecol.95, 692–696 (2000).
  • Manfredi R, Mirk P, Maresca C et al. Local-regional staging of endometrial carcinoma: role of MR imaging in surgical planning. Radiology231, 372–378 (2004).
  • Taïeb S, Ceugnart L, Leblanc E, Chevalier A, Cabaret V, Querleu D. IRM des cancers de l’endomètre: apports et limites. Bull. Cancer89, 693–698 (2002).
  • Ascher SM, Cooper C, Scoutt L, Imaoka I, Hricak H. Diagnostic imaging techniques in gynecologic oncology. In: Principles and Practice of Gynecologic Oncology. Hoskins WJ (Ed.), Lippincott Williams and Wilkins, PA, USA 223–268 (2005).
  • Belhocine T, de Barsy C, Hustinx R, Willems-Foidart J. Usefulness of 18F-FDG PET in the post-therapy surveillance of endometrial cancer. Eur. J. Nucl. Med. Mol. Imaging29, 1132–1139 (2002).
  • Tingulstad S, Skjeldestad FE, Halvorsen TB, Hagen B. Survival and prognostic factors in patients with ovarian cancer. Obstet. Gynecol.101, 885–891 (2003).
  • La Fianza A, Campani R, Dore R, Babilonti L, Tateo S. The clinical value of computed tomography and lymphography in detecting lymph node metastases from epithelial ovarian cancer. Fortschr. Röntgenstr.157, 162–166 (1992).
  • Burghardt E, Girardi F, Lahousen M, Tamussino K, Stattner H. Patterns of pelvic and paraaortic lymph node involvement in ovarian cancer. Gynecol. Oncol.40, 103–106 (1991).
  • Benedetti Panici P, Maggioni A, Hacker N et al. Systematic aortic and pelvic lymphadenectomy versus resection of bulky nodes only in optimally debulked advanced ovarian cancer: a randomized clinical trial. J. Natl. Cancer Inst.97, 560–566 (2005).
  • Tempany CM, Zou KH, Silverman SG, Brown DL, Kurtz AB, McNeil BJ. Staging of advanced ovarian cancer: comparison of imaging modalities – report from the Radiological Diagnostic Oncology Group. Radiology215(3), 761–767 (2000).
  • Sugiyama Y, Nishida T, Ushijima K et al. Detection of lymph node metastasis in ovarian carcinoma and uterine corpus carcinoma by preoperative computerized tomography or magnetic resonance imaging. J. Obstet. Gynaecol.21, 551–556 (1995).
  • Petru E, Schmidt F, Mikosch P et al. Abdominopelvic computed tomography in the preoperative evaluation of suspected ovarian masses. Int. J. Gynecol. Cancer5, 252–255 (1992).
  • Medl M, Kulenkampff KJ, Stiskal M, Peters-Engl C, Leodolter S, Czembirek H. Magnetic resonance imaging in the preoperative evaluation of suspected ovarian masses. Anticancer Res.15, 1123–1126 (1995).
  • Kurtz AB, Tsimikas JV, Tempany CM et al. Diagnosis and staging of ovarian cancer: comparative values of Doppler and conventional US, CT, and MR imaging correlated with surgery and histopathologic analysis – report of the Radiology Diagnostic Oncology Group. Radiology212(1), 19–27 (1999).
  • Sohaib SA, Moskovic EC. Imaging in vulval cancer. Best Pract. Res. Clin. Obstet. Gynaecol.17(4), 543–556 (2003).
  • Soper JT. Radiographic imaging in gynecologic oncology. Clin. Obstet. Gynecol.44(3), 485–494 (2001).
  • Rouzier R, Haddad B, Dubernard G, Dubois P, Paniel BJ. Inguinofemoral dissection for carcinoma of the vulva: effect of modifications of extent and technique on morbidity and survival. J. Am. Coll. Surg.196, 442–450 (2003).
  • Zhang SH, Sood AK, Sorosky JI, Anderson B, Buller RE. Preservation of the saphenous vein during inguinal lymphadenectomy decreases morbidity in patients with carcinoma of the vulva. Cancer89, 1520–1525 (2000).
  • Hall TB, Barton DP, Trott PA et al. The role of ultrasound-guided cytology of groin lymph nodes in the management of squamous cell carcinoma of the vulva: 5-year experience in 44 patients. Clin. Radiol.58(5), 367–371 (2003).
  • Hawnaur JM, Reynolds K, Wilson G, Hillier V, Kitchener HC. Identification of inguinal lymph node metastases from vulval carcinoma by magnetic resonance imaging: an initial report. Clin. Radiol.57(11), 995–1000 (2002).
  • Land R, Herod J, Moskovic E et al. Routine computerized tomography scanning, groin ultrasound with or without fine needle aspiration cytology in the surgical management of primary squamous cell carcinoma of the vulva. Int. J. Gynecol. Cancer16, 312–317 (2006).
  • Abang Mohammed DK, Uberoi R, de B Lopes A, Monaghan JM. Inguinal node status by ultrasound in vulva cancer. Gynecol. Oncol.77(1), 93–96 (2000).
  • Moskovic EC, Shepherd JH, Barton DP, Trott PA, Nasiri N, Thomas JM. The role of high resolution ultrasound with guided cytology of groin lymph nodes in the management of squamous cell carcinoma of the vulva: a pilot study. Br. J. Obstet. Gynaecol.106, 863–867 (1999).
  • Sohaib SA, Richards PS, Ind T et al. MR imaging of the vulva. Am. J. Roentgenol.178, 373–377 (2002).
  • Cohn DE, Dehdashti F, Gibb RK et al. Prospective evaluation of positron emission tomography for the detection of groin node metastases from vulvar cancer. Gynecol. Oncol.85(1) , 179–184 (2002).
  • Averette HE, Ford JH, Dudan RC, Girtanner RE, Hoskins WJ, Lutz MH. Staging of cervical cancer. Clin. Obstet. Gynecol.18(3), 215–232 (1975).
  • Lagasse LD, Creasman WT, Shingleton HM, Ford JH, Blessing JA. Results and complications of operative staging in cervical cancer: experience of the Gynecologic Oncology Group. Gynecol. Oncol.9(1), 90–98 (1980).
  • Benedet JL, Odicino F, Maisonneuve P et al. Carcinoma of the cervix uteri. Int. J. Gynaecol. Obstet.83, 41–78 (2003).
  • Logmans A, Kruyt RH, de Bruin HG, Cox PH, Pillay M, Trimbos JB. Lymphedema and lymphocysts following lymphadenectomy may be prevented by omentoplasty: a pilot study. Gynecol. Oncol.75(3), 323–327 (1999).
  • Martimbeau PW, Kjorstad KE, Kolstad P. Stage IB carcinoma of the cervix, the Norwegian Radium Hospital, 1968–1970: results of treatment and major complications. I. Lymphedema. Am. J. Obstet. Gynecol.131(4), 389–394 (1978).
  • Raatz D, Borner P. Laparoscopy assisted radical vaginal hysterectomy (LAVRH) for cervical carcinoma – perioperative parameters and complications. Zentralbl. Gynakol.123(3), 136–142 (2001).
  • Bortolozzi G, Mangili G, Raimondo V, Uderzo A, Zanetta M. Le complicanze linfatiche nella terapia del cervico-carcinoma clinico. Casistica del decennio 1971–1980 (1.157 pazienti). Ann. Ost. Gin. Med. Perin.107, 296–304 (1986).
  • Mamsen A, Ledertoug S, Hørlyck A et al. The possible role of ultrasound in early cervical cancer. Gynecol. Oncol.56, 187–190 (1995).
  • Cheung TH, Yang WT, Yu MY, Lo WK, Ho SH. New development of laparoscopic ultrasound and laparoscopic pelvic lymphadenectomy in the management of patients with cervical carcinoma. Gynecol. Oncol.71, 87–93 (1998).
  • Yang WT, Lam WW, Yu MY, Cheung TH, Metreweli C. Comparison of dynamic helical CT and dynamic MR imaging in the evaluation of pelvic lymph nodes in cervical carcinoma. Am. J. Roentgenol.175(3), 759–766 (2000).
  • Kim SH, Choi BI, Lee HP et al. Uterine cervical carcinoma: comparison of CT and MR findings. Radiology175, 45–51 (1990).
  • Kim SH, Choi BI, Han JK et al. Preoperative staging of cervical carcinoma: comparison of CT and MRI in 99 patients. J. Comput. Assist. Tomogr.17, 633–640 (1993).
  • Bellomi M, Bonomo G, Landoni F et al. Accuracy of computed tomography and magnetic resonance imaging in the detection of lymph node involvement in cervix carcinoma. Eur. Radiol.15(12), 2469–2474 (2005).
  • Subak LL, Hricak H, Powell CB, Azizi L, Stern JL. Cervical carcinoma: computed tomography and magnetic resonance imaging for preoperative staging. Obstet. Gynecol.86, 43–50 (1995).
  • Oellinger JJ, Blohmer JU, Michniewicz K et al. Pre-operative staging of cervical cancer: comparison of magnetic resonance imaging (MRI) and computed tomography (CT) with histologic results. Zentralbl. Gynakol.122, 82–91 (2000).
  • Genolet PM, Hänggi W, Dreher E. Bilan d’extension tumorale lors de cancer invasif du col utérin. Gynäk. Geburtshilfliche. Rundsch.33, 180–184 (1993).
  • Kokka F, Vorgias G, Tserkezoglou A et al. Preoperative work-up of early cervical cancer (stages Ib–IIa). Eur. J. Gynaec. Oncol.24, 175–177 (2003).
  • Bipat S, Glas AS, van der Velden J, Zwinderman AH, Bossuyt PM, Stoker J. Computed tomography and magnetic resonance imaging in staging of uterine cervical carcinoma: a systematic review. Gynecol. Oncol.91, 59–66 (2003).
  • Narayan K, Hicks RJ, Jobling T, Bernshaw D, McKenzie AF. A comparison of MRI and PET scanning in surgically staged loco-regionally advanced cervical cancer: potential impact on treatment. Int. J. Gynecol. Cancer.11, 263–271 (2001).
  • Park W, Park YJ, Huh SJ et al. The usefulness of MRI and PET imaging for the detection of parametrial involvement and lymph node metastasis in patients with cervical cancer. Jpn. J. Clin. Oncol.35, 260–264 (2005).
  • Belhocine T, Thille A, Fridman V et al. Contribution of whole-body 18FDG PET imaging in the management of cervical cancer. Gynecol. Oncol.78, 90–97 (2002).
  • Yu KK, Hricak H, Subak LL, Zaloudek CJ, Powell CB. Preoperative staging of cervical carcinoma: phased array coil fast spin-echo versus body coil spin-echo T2-weighted MR imaging. Am. J. Roentgenol.171, 707–711 (1998).
  • Sheu MH, Chang CY, Wang JH, Yen MS. Preoperative staging of cervical carcinoma with MR imaging: a reappraisal of diagnostic accuracy and pitfalls. Eur. Radiol.11, 1828–1833 (2001).
  • Hawighorst H, Schoenberg SO, Knapstein PG et al. Staging of invasive cervical carcinoma and of pelvic lymph nodes by high resolution MRI with a phased-array coil in comparison with pathological findings. J. Comput. Assist. Tomogr.22, 75–81 (1998).
  • Wang LJ, Wong YC, Chen CJ, Huang KG, Hsueh S. Cervical carcinoma: MR imaging with integrated endorectal/phased-array coils: a pilot study. Eur. Radiol.11, 1822–1827 (2001).
  • Heuck A, Scheidler J, Kimmig et al. Lymph node staging in cervix cercinomas: the results of high-resolution magnetic resonance tomography (MRT) with a phased-array coil. Röfo.166, 210–215 (1997).
  • Reinhardt MJ, Ehritt-Braun C, Vogelgesang D et al. Metastatic lymph nodes in patients with cervical cancer: detection with MR imaging and FDG PET. Radiology218, 776–782 (2001).
  • Kim SH, Kim SC, Choi BI, Han MC. Uterine cervical carcinoma: evaluation of pelvic lymph node metastasis with MR imaging. Radiology190, 807–811 (1994).
  • Choi HJ, Roh JW, Seo SS et al. Comparison of the accuracy of magnetic resonance imaging and positron emission tomography/computed tomography in the presurgical detection of lymph node metastasis in patients with uterine cervical carcinoma. Cancer106, 914–922 (2006).
  • Hawnaur JM, Johnson RJ, Buckley CH, Tindall V, Isherwood I. Staging, volume estimation and assessment of nodal status in carcinoma of the cervix: comparison of magnetic resonance imaging with surgical findings. Clin. Rad.49, 443–452 (1994).
  • Choi SH, Kim SH, Choi HJ, Park BK, Lee HK. Preoperative magnetic resonance imaging staging of uterine cervical carcinoma. J. Comput. Assist. Tomogr.28, 620–627 (2004).
  • Rose PG, Adler LP, Rodriguez M, Faulhaber PF, Abdul-Karim FW, Miraldi F. Positron emission tomography for evaluating para-aortic nodal metastasis in locally advanced cervical cancer before surgical staging: a surgicopathologic study. J. Clin. Oncol.17, 41–45 (1999).
  • Kühnel G, Horn LC, Fischer U et al.18F-FDG-Positronen-Emissions-Tomographie bei Zervixkarzinom: erste Ergebnisse. Zentralbl. Gynakol.123, 229–235 (2001).
  • Chou HH, Chang TC, Yen TC et al. Low value of [18F]-fluoro-2-deoxy-d-glucose positron emission tomography in primary staging of early-stage cervical cancer before radical hysterectomy. J. Clin. Oncol.24, 123–128 (2006).
  • Scheidler J, Hricak H, Yu KK, Subak L, Segal MR. Radiological evaluation of lymph node metastases in patients with cervical cancer. JAMA278, 1096–1101 (1997).
  • Boss EA, Barentsz JO, Massuger LF, Boonstra H. The role of MR imaging in invasive cervical carcinoma. Eur. Radiol.10, 256–270 (2000).
  • Sironi S, Buda A, Picchio M et al. Lymph node metastasis in patients with early-stage cervical cancer: detection with integrated FDG PET/CT. Radiology283, 272–279 (2006).
  • Weissleder R, Elizondo G, Wittenberg J, Lee AS, Josephson L, Brady TJ. Ultrasmall superparamagnetic iron oxide: an intravenous contrast agent for assessing lymph nodes with MR imaging. Radiology175(2), 494–498 (1990).
  • Anzai Y, Prince MR. Iron oxide-enhanced MR lymphography: the evaluation of cervical lymph node metastases in head and neck cancer. J. Magn. Reson. Imaging7(1), 75–81 (1997).
  • Vassallo P, Matei C, Heston WD, McLachlan SJ, Koutcher JA, Castellino RA. AMI-227-enhanced MR lymphography: usefulness for differentiating reactive from tumor-bearing lymph nodes. Radiology193(2), 501–506 (1994).
  • Hudgins PA, Anzai Y, Morris MR, Lucas MA. Ferumoxtran-10, a superparamagnetic iron oxide as a magnetic resonance enhancement agent for imaging lymph nodes: a Phase 2 dose study. Am. J. Neuroradiol.23(4), 649–656 (2002).
  • Harisinghani MG, Barentsz J, Hahn PF et al. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N. Engl. J. Med.348(25), 2491–2499 (2003).
  • Keller TM, Michel SC, Fröhlich J et al. USPIO-enhanced MRI for preoperative staging of gynecological pelvic tumors: preliminary results. Eur. Radiol.14, 937–944 (2004).
  • Rockall AG, Sohaib SA, Harisinghani MG et al. Diagnostic performance of nanoparticle-enhanced magnetic resonance imaging in the diagnosis of lymph node metastases in patients with endometrial and cervical cancer. J. Clin. Oncol.23(12), 2813–2821 (2005).
  • Will O, Purkayastha S, Chan C et al. Diagnostic precision of nanoparticle-enhanced MRI for lymph node metastasis: a meta-analysis. Lancet Oncol.7, 52–60 (2006).
  • Anzai Y, Piccoli CW, Outwater EK et al. Evaluation of neck and body metastases to nodes with ferumoxtran 10-enhanced MR imaging: Phase III safety and efficacy study. Radiology228(3), 777–788 (2003).
  • Harisinghani MG, Weissleder R. Sensitive, noninvasive detection of lymph node metastases. PloS. Med.1(3), 202–209 (2004).
  • Takahara T, Imai Y, Yamashita T, Yasuda S, Nasu S, Van Cauteren M. Diffusion weighted whole body imaging with background body signal suppression (DWIBS): technical improvement using free breathing, STIR and high resolution 3D display. Radiat. Med.22(4), 275–282 (2004).
  • Guo Y, Cai YQ, Cai ZL et al. Differentiation of clinically benign and malignant breast lesions using diffusion-weighted imaging. J. Magn. Reson. Imaging16(2), 172–178 (2002).
  • Naganawa S, Sato C, Kumada H, Ishigaki T, Miura S, Takizawa O. Apparent diffusion coefficient in cervical cancer of the uterus: comparison with the normal uterine cervix. Eur. Radiol.15(1), 71–78 (2005).
  • Woodhams R, Matsunaga K, Iwabuchi K et al. Diffusion-weighted imaging of malignant breast tumors: the usefulness of apparent diffusion coefficient (ADC) value and ADC map for the detection of malignant breast tumors and evaluation of cancer extension. J. Comput. Assist. Tomogr.29(5), 644–649 (2005).
  • Sumi M, Sakihama N, Sumi T et al. Discrimination of metastatic cervical lymph nodes with diffusion-weighted MR imaging in patients with head and neck cancer. Am. J. Neuroradiol.24(8), 1627–1634 (2003).
  • Pickles MD, Gibbs P, Sreenivas M, Turnbull LW. Diffusion-weighted imaging of normal and malignant prostate tissue at 3.0T. J. Magn. Reson. Imaging23(2), 130–134 (2006).
  • Chiu FY, Jao JC, Chen CY et al. Effect of intravenous gadolinium-DTPA on diffusion-weighted magnetic resonance images for evaluation of focal hepatic lesions. J. Comput. Assist. Tomogr.29(2), 176–180 (2005).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.